人乳头状瘤病毒相关口咽鳞状细胞癌经根治性治疗后复发患者的结局
本文为单中心回顾性研究,纳入1996至2014年间初始接受经口手术治疗的人乳头状瘤病毒(HPV)相关口咽鳞状细胞癌(OPSCC)患者279例,其中38例(13.6%)复发;21例(7.5%)为局部区域复发,18例接受根治性治疗,其3年总生存率为75.3%(95%CI 54.3-96.0),中位随访33个月(范围5-65);4例接受根治性治疗的孤立远处转移患者均随后出现第二次疾病复发。作者结论认为,经口手术后孤立局部区域复发的挽救性根治治疗与良好预后相关,应提供给合适的候选患者。
要点
- 279例经口手术治疗的HPV相关OPSCC患者中38例(13.6%)复发,21例(7.5%)为局部区域复发。
- 18例局部区域复发接受根治性治疗,3年总生存率75.3%(95%CI 54.3-96.0),中位随访33个月(范围5-65)。
- 4例孤立远处转移接受根治性治疗者均随后出现第二次疾病复发。
核心结论
- 经口手术后孤立局部区域复发的挽救性根治治疗与良好预后相关,应提供给合适的候选患者。
研究设计与样本
- 单中心回顾性研究,纳入1996至2014年间初始接受经口手术(TOS)治疗、后出现根治性治疗的局部区域复发或单部位远处复发的HPV相关OPSCC患者。
主要发现
- 279例患者中38例(13.6%)复发,其中21例(7.5%)为局部区域复发。
- 21例局部区域复发中18例接受根治性治疗,其3年总生存率为75.3%(95%CI 54.3-96.0),中位随访33个月(范围5-65)。
- 4例孤立远处转移接受根治性治疗的患者均随后出现第二次疾病复发。
临床怎么用
- 作者认为,经口手术后孤立局部区域复发的挽救性根治治疗与良好预后相关,应提供给合适的候选患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With most centers reporting excellent disease control following transoral surgery for human papillomavirus (HPV)-related oropharyngeal cancer, data are still lacking regarding management and outcomes in patients who relapse. We describe the treatment outcomes after curative intent therapy for locoregional and distant relapse following transoral surgery for HPV-related oropharyngeal squamous cell carcinoma (OPSCC). METHODS: A single institution retrospective study in which patients were identified with curatively treated loco-regional or single site distant relapse of HPV-related OPSCC treated initially with transoral surgery (TOS) between 1996 and 2014. RESULTS: Among 279 patients, 38 (13.6%) relapsed. 21 (7.5%) had local-regional relapse and 18 were treated with curative intent. Three-year overall survival for loco-regional recurrence with curatively intended treatment was 75.3% (95% confidence intervals 54.3-96.0) with a median follow-up 33 (range: 5-65) months. Among 4 patients with isolated distant metastasis who were treated with curative intent, all subsequently developed second relapse of disease. CONCLUSION: Salvage curative treatment of isolated local-regional relapse after TOS is associated with favorable prognosis and should be offered in appropriate candidates.
引用
- Pipkorn P, Sinha P, Kallogjeri D, et al. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent. Head Neck. 2018. PMID: 30536710. doi:10.1002/hed.25557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。